Deqi Pharmaceuticals-B (06996.HK) plans to conduct on-market share repurchase.

The Zhitong Finance APP reported that Daichii Pharmaceuticals-B (06996.HK) has announced that it intends to exercise its relevant rights based on the general authorization granted by the company's shareholders at the annual general meeting held on June 10, 2026, to repurchase up to 67,924,000 shares of the company, which is 10% of the total number of issued shares as of the date of the shareholders' annual general meeting (excluding any treasury shares).